Acquiring Company
Essity
Acquired Company
Kenvue
Stockholm
SummitManufacturingHealth CareDescription
Essity has agreed to acquire Kenvue’s feminine care business in Brazil, which includes the Carefree, Sempre Livre, and o.b. brands, for US$284 million. The acquisition aims to strengthen Essity's market position and growth strategy in feminine care within Brazil. The transaction is expected to close in the second quarter of 2027, pending regulatory approvals. This acquisition follows Essity's recent expansion efforts in the region.
Don't miss Essity's next move
Get an email the moment Essity makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Kenvue?
Kenvue was acquired by Essity, based in Stockholm. The deal was reported on August 19, 2026. Essity is privately held and operates in Manufacturing.
When did Essity acquire Kenvue?
Essity's acquisition of Kenvue was reported on August 19, 2026. Essity has agreed to acquire Kenvue’s feminine care business in Brazil, which includes the Carefree, Sempre Livre, and o.b. brands, for US$284 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kenvue do?
Kenvue is a consumer health spinoff of Johnson & Johnson, specializing in global corporate affairs and a portfolio of brands including Band-Aid, Listerine, Tylenol, and Neutrogena. It is publicly traded (KVUE), operating in Health Care, and is based in Summit.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.